X0508 4 2025-03-01 0001682852 Moderna, Inc. MRNA 0001443340 Bancel Stephane C/O MODERNA, INC. 325 BINNEY STREET CAMBRIDGE MA 02142 1 1 Chief Executive Officer 0 Common Stock 5493897 D Common Stock 9050372 I See Footnote Common Stock 6564880 I See Footnote Stock Option (Right to Buy) 30.96 2025-03-01 4 A 0 357065 0 A 2026-03-01 2035-03-01 Common Stock 357065 357065 D These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. /s/ James Dillon, as Attorney-in-Fact 2025-03-03